Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Nexavar
Biotech
AstraZeneca posts rare cancer win for treme, beating Nexavar
After multiple flops, AstraZeneca has reported improved survival in a phase 3 checkpoint inhibitor combination study in liver cancer patients.
Nick Paul Taylor
Oct 15, 2021 8:15am
MiNA raises $30M to take small activating RNA into phase 2
Sep 10, 2020 7:05am
Phase 3 trial of Transgene's oncolytic virus halted for futility
Aug 2, 2019 7:50am
Novartis offloads failed cancer drug to Oncology Venture
Apr 10, 2018 9:15am
Phase 3 hepatocellular carcinoma fail crushes Onxeo
Sep 12, 2017 10:12am
Aveo takes baby step forward for once-rejected tivozanib
Feb 23, 2017 10:23am
